Endoscopic Retrograde Cholangiopancreatography




Endoscopic retrograde cholangiopancreatography (ERCP) has become enormously popular throughout the world because of its proven value in the management of patients with known and suspected biliary and pancreatic disease. The results of ERCP are operator dependent, and there are significant risks. Adverse events are more likely when procedures are performed by endoscopists with inadequate training and experience. The best outcomes should occur when procedures are done for the best reasons, using optimal techniques in an ideal environment and a well-trained team, conscious of the risks and the ways to minimize them. This article discusses these intertwining elements of ERCP.








  • Endoscopic retrograde cholangiopancreatography (ERCP) has become enormously popular throughout the world because of its proven value in the management of patients with known and suspected biliary and pancreatic disease.



  • Like all invasive interventions, the results of ERCP are operator dependent, and there are significant risks.



  • Adverse events can occur in the best of hands, but are more likely when procedures are performed by endoscopists with inadequate training and experience.



  • Quality has been described as “doing the right thing, and doing it right.” The best outcomes should occur when procedures are done for the best reasons, using optimal techniques in an ideal environment, by the best team, conscious of the risks and the best ways to minimize them.



Key Points
Endoscopic retrograde cholangiopancreatography (ERCP) has become enormously popular throughout the world because of its proven value in the management of patients with known and suspected biliary and pancreatic disease. Like all invasive interventions, the results of ERCP are operator dependent, and there are significant risks. Adverse events can occur in the best of hands, but are more likely when procedures are performed by endoscopists with inadequate training and experience. Practitioners (and their professional organizations), payors, and patients (and plaintiffs) should all be interested in ensuring the highest possible benefit/risk ratios in ERCP practice. Quality has been described as “doing the right thing, and doing it right.” The best outcomes should occur when procedures are done for the best reasons, using optimal techniques in an ideal environment and a well-trained team, conscious of the risks and the ways to minimize them. These intertwining elements are discussed sequentially in this article.


Doing the right thing


An ERCP procedure, like any other, may be recommended for many reasons: to make or refine a diagnosis, to assess the status of a known disease (surveillance), to screen for disease, to take target specimens, to provide treatment, or combinations of the above. For any one patient, the overall goal of the procedure is framed by the specific clinical context, which can be described by many elements, including symptoms (eg, jaundice or pain), findings (eg, laboratory tests and images), prior surgery (eg, cholecystectomy), comorbidities, and other factors increasing risk or complexity.


Indications


Professional societies such as the American Society for Gastrointestinal Endoscopy (ASGE) have produced lists of approved indications ( Box 1 ), and include adherence to them as key metrics of procedural quality.



Box 1




  • A.

    Jaundice thought to be the result of biliary obstruction


  • B.

    Clinical and biochemical or imaging data suggestive of pancreatic or biliary tract disease


  • C.

    Signs or symptoms suggesting pancreatic malignancy when direct imaging results are equivocal or normal


  • D.

    Pancreatitis of unknown etiology


  • E.

    Preoperative evaluation of chronic pancreatitis or pancreatic pseudocyst


  • F.

    Sphincter of Oddi manometry


  • G.

    Endoscopic sphincterotomy



    • 1.

      Choledocholithiasis


    • 2.

      Papillary stenosis or sphincter of Oddi dysfunction causing disability


    • 3.

      Facilitate biliary stent placement or balloon dilatation


    • 4.

      Sump syndrome


    • 5.

      Choledochocele


    • 6.

      Ampullary carcinoma in poor surgical candidates


    • 7.

      Access to pancreatic duct



  • H.

    Stent placement across benign or malignant strictures, fistulae, postoperative bile leak, or large common bile duct stones


  • I.

    Balloon dilatation of ductal strictures


  • J.

    Nasobiliary drain placement


  • K.

    Pseudocyst drainage in appropriate cases


  • L.

    Tissue sampling from pancreatic or bile ducts


  • M.

    Pancreatic therapeutics



Indications for ERCP


Review of this list of ASGE indications reveals its obvious shortcomings. The legitimacy of many of the indications (eg, A through E) depends entirely on the extent of the prior workup, and the level of diagnostic suspicion. Item B is so broad as to be virtually meaningless. F says that sphincter of Oddi manometry is an approved indication, but clearly that would depend entirely on the clinical context. Indication K begs the question, by stating “pseudocyst drainage in appropriate cases.” M states that “pancreatic therapeutics” is an indication, but surely also only in “appropriate cases.”


Furthermore, ERCP is not performed in a technical vacuum. There is now a plethora of relevant diagnostic procedures such as magnetic resonance cholangiopancreatography and endoscopic ultrasonography, which may obviate ERCP or better focus its application. In addition, surgery has become much safer over the years, and may well provide more definitive treatment in some contexts, for example, chronic pancreatitis. The report from the National Institutes of Health (NIH) “state of the science” conference on ERCP made many comments on alternative approaches and quality issues.


Careful consideration of these alternatives (and the level of expertise available locally) is needed before concluding that ERCP is the legitimate procedure of choice in the precise patient and clinical context. This aspect is often the issue in lawsuits when it is argued that something less invasive than ERCP might have been preferred. These issues and the evidence behind them are discussed in articles elsewhere in this issue that deal with individual clinical contexts.


Better ways to document the reasons for doing a procedure (the indication)


Endoscopy reports traditionally include the indication for the procedure. An important practical issue is how to express this succinctly and meaningfully, especially in electronic reporting systems, which demand structured data sets. For the reasons argued above, simply ticking a box of ASGE-approved indications is insufficient. It is preferable to define and document all of the individual elements that go into making a procedural recommendation in a matrix:




  • Overall goal



  • Planned procedures (strategy)



  • Symptoms



  • Known and suspected diseases



  • Recent laboratory tests and images



  • Prior surgeries



  • Prior interventions (eg, prior stents)



  • Comorbidities and risk factors.



This matrix would be comprehensive, allow some detailed research analysis, and might help in medicolegal conflicts, whereby the need for the (complicated) procedure is often at issue. The data entered could also easily be mapped to any other proposed list, because it will contain all of the elements. However, these lists would be long, and most endoscopists will argue that the details should already be available in their preprocedure clinical report (assuming that there is one). A simpler approach is to note the general clinical context, as is used in the ERCP Quality Network ( Box 2 ).



Box 2





  • Obstructive jaundice



  • Abnormal liver tests



  • Stone, known or probable



  • Pancreatitis, acute, active



  • Pancreatitis, idiopathic, recurrent



  • Pancreatitis, chronic



  • Pancreatic pseudocyst/leak



  • Pain—chronic, ?cause



  • Pain—intermittent, eg, postcholecystectomy (includes? sphincter of Oddi dysfunction)



  • Biliary postsurgical problem (leak, stricture)



  • Stent service, biliary (ie, change or remove)



  • Stent service, pancreatic (ie, change or remove)



  • Clarify biliary image findings



  • Clarify pancreatic image findings



  • Tumor ablation



  • Other context



Procedural contexts in the ERCP Quality Network


A similar approach is taken in the latest iteration of the Minimal Standard Terminology (MST 3.0), where indications are replaced by “reasons for” procedures. The endoscopist has simply to pick a suspected (or known) diagnosis, and add whether the goal is to make or refine a diagnosis, perform therapy, take specimens, or do surveillance or screening.




Doing it right


Patients and their caregivers expect that their procedures will be performed for the right reasons but also expeditiously, skillfully, successfully, safely, and comfortably. These expectations can be expanded to make a list of desirable characteristics for all types of endoscopic procedures.




  • Competent endoscopist



  • Appropriate environment, support team, and behavior



  • Adequate information



  • Strategies to minimize risk, including preprocedure evaluation and monitoring



  • Appropriate use of medications, including sedation/analgesia



  • Correct selection of equipment, well maintained and processed



  • Complete survey of the target organ(s)



  • Recognition of all abnormalities, and photodocumentation



  • Appropriate tissue sampling



  • Application of indicated therapy



  • Reasonable duration of procedure and any fluoroscopy



  • Smooth recovery, explanation, and discharge



  • Recognizing, and managing, adverse events



  • Clear explanations, recommendations, and follow-up plans



  • Integrated pathology results and necessary communications



  • Complete documentation.



Many organizations and groups have explored these quality issues and their metrics. Most attention has been directed toward the contentious and complex issue of endoscopist competence.


What is a Competent Endoscopist?


In discussing competence it is important to appreciate that ERCP is not a single procedure, but simply describes a method for accessing the biliary system and pancreas through the mouth, for diagnostic and therapeutic interventions. There are many clinical situations for which it may be appropriate, and many techniques and therapies that can be applied. More than 10 years ago, Schutz and Abbot introduced a grading system for “degrees of difficulty,” which was intended to help plan ERCP training programs and to define levels of practice. It has been in widespread use subsequently, and divides ERCP practice into 3 levels. Grade 1, or standard, cases are those commonly needed in the community, and include management of bile duct stones (<10 mm), malignant biliary strictures below the hilum, and postoperative biliary leaks. Grade 2 (advanced) includes more complex cases, including: diagnostic ERCP after Billroth II gastrectomy; management of larger stones, benign biliary strictures, and hilar tumors; and minor papilla cannulation. Grade 3 are those cases usually restricted to tertiary centers, including suspected sphincter of Oddi dysfunction, therapeutics after surgical biliary diversion, intrahepatic stones, and all pancreatic therapies. ERCP has changed over the years, and an ASGE working party recently revised the grading system.


These complexity-grading systems have obvious implications for training and practice. Most fellowship programs in the United States attempt only to bring trainees to competence in basic-level procedures (if they offer ERCP training at all). The early assumption that endoscopists might become competent in basic ERCP after being involved in 100 procedures was shown to be far short of the mark by a seminal study from Jowell and colleagues. Their fellows at Duke University were barely achieving 80% competence in basic skills after 180 to 200 cases. Several countries have used this number subsequently as a threshold for competence assessment, but Australia has gone further, and now requires completion of 200 procedures without assistance. Substantially more training, for instance 300 more cases, is required to approach competence in more complex cases, and some will eventually become true experts after years of high-volume practice.


Who Will Do Your ERCP?


Highly skilled ERCPists have technical success rates approaching 100% for most procedures, at least those at basic grade 1. However, not all patients can be managed by these experts. The issue then is how to determine who decides what constitutes acceptable performance, and how patients know who to consult, or maybe who to avoid. Would you let your recent trainee loose on your family? Would you yourself submit to an 80% to 85% ERCPist? This level of performance would be acceptable, perhaps life-saving, in an urgent and remote situation, but certainly not for an elective procedure when experts are available nearby. Those of us working in gastroenterology usually have a reasonably good idea who to refer ERCP cases to (or to consult oneself), based on local reputation and track record. If in doubt, it is often wise to ask the nursing staff! But how is the average patient to know who is competent? ERCP is different from other endoscopies in that it is virtually always performed in hospitals, which have systems for assessing competence and granting privileges. One might assume that hospitals grant privileges only after careful review of relevant data, such as the nature and extent of training, subsequent practice (if any), continuing education, and some performance statistics, as recommended by ASGE and other organizations. However, the author suspects that the process is often more cursory, consisting only of a letter from the training institution. Those writing such letters are smart enough usually simply to confirm that training has been given, not that competence has been achieved. Both training directors and hospitals have been sued for allegedly supporting privileges for endoscopists who have had bad outcomes. It is noteworthy that privileges for ERCP are usually all or none. It would be logical to use the complexity-grading system to allocate levels of privilege.


Proof of competence can only be derived from documentation of performance. There is no substitute for collecting relevant data. Trainees in most countries are now expected to maintain logbooks of their procedural activity during training, and the ASGE and other authorities have recommended that endoscopists should collect data prospectively on their endoscopic practice and performance with “report cards.”


Report cards and benchmarking performance


Endoscopists cannot be expected to populate their report cards with all of the data elements that have been listed in various well-meaning publications. Items should be selected based on ease of data collection, and by assumed relative importance. Some items are easily recorded, and already appear in most procedure reports (eg, anatomic extent, duration, diagnosis, treatments, immediate adverse events). Other items are more subjective (eg, lesion interpretation), or more difficult to record (eg, delayed events, endoscopist-specific patient satisfaction). Some items would appear to be more important markers of quality than others. For ERCP, selective cannulation and stone extraction rates are obvious key parameters.


Once several practitioners agree to share their data, they can compare their practices and levels of performance with those of their peers and “competitors,” which requires organization as well as motivation.


With the support of Olympus America, the author’s group set up a pilot project, the ERCP Quality Network, to test the practicality and acceptability of collecting and comparing data on the practice and quality of ERCP procedures by individual endoscopists. Baseline information included the experience and practice environment of the endoscopists. Data on each procedure are loaded onto a secure Web site. The data points include the clinical context (indications), complexity grade, American Society of Anesthesiologists (ASA) grade, sedation/anesthesia, admission policy, scope and fluoroscopy times, and success rates for individual technical procedures such as deep biliary cannulation, sphincterotomy, stenting, and adverse events. There are no patient identifiers. The data are analyzed automatically, and results posted immediately on the Web site. Contributors can view a summary of their own performance (report card), and compare it with that of all other contributors to the system (benchmarking), not identified by name. To date, more than 150 ERCPists from several countries have entered data on more than 25,000 cases. The variation in individual biliary cannulation rates is shown in Fig. 1 .




Fig. 1


Average biliary cannulation rates by individual endoscopists in the ERCP Quality Network.


The Quality Network project shows that data can be collected, shared, and compared by a small number of enthusiastic volunteers, with some commercial support. What might motivate the main body of practitioners? Ultimately, informed consumers will drive this agenda. Practitioners with poor outcomes, or those who choose not to provide data, will be disadvantaged. Keeping a report card will provide a competitive advantage, as intelligent patients will increasingly wish to have greater control over their treatments. It should also provide some medicolegal protection, and will eventually be a crucial tool in the evolving use of “pay for performance” in the United States. The increasing use of electronic endoscopy reporting systems will make this process easy, even automatic.


Is ongoing volume important?


It is logical to assume that anyone offering ERCP should be doing it on a regular basis, to maintain skills and, hopefully, to continue to improve. Several studies have shown that more is better, but none have data sufficient to define a minimum number (mainly because the lower-volume practitioners do not publish their results). The number probably varies according to the extent of prior practice and the volume of the institution. The British Society of Gastroenterology (BSG) has recommended a minimum of 75 per year. A recent survey of ERCP practice among more than 1000 ASGE members showed that 40% were doing less than 50 per year, data that stimulated an editorial entitled “Are low-volume ERCPists a problem in USA?”


Teamwork and environment


As ERCP has become almost completely therapeutic its needs have become more complex, and increasingly resemble those of traditional surgery, that is, purpose-designed rooms with high-quality fluoroscopy, complex equipment, sterility (where possible), anesthesia, and specially trained staff. Doing complex procedures on uncomfortable patients in unfamiliar territory with untrained staff is a recipe for failure and potential disaster, and this is more likely to be the case in centers with low volumes of ERCP. Recognizing this issue, the BSG has suggested that ERCP should only be performed in centers with more than 200 cases per year. In such light it is striking that a recent survey suggests that about half of all hospitals offering ERCP in the United States do less than 50 per year.


What are the Benefits of ERCP?


Doing the right thing and doing it right should maximize the benefit from an individual procedure, but measuring that benefit is difficult. It can be determined only if the goal is defined beforehand, and the metrics of benefit vary according to the stated goal. Technical success (eg, removal of a stone or placement of a stent) is easy to assess immediately. However, clinical success is a much more elusive and potentially subjective matter, not least because of the time scales involved. Whether sphincterotomy helps a patient with suspected sphincter of Oddi dysfunction, or stenting helps someone with a pancreatic stricture, cannot be assessed until many months have passed. Even if things seem to go well initially, relapse is not unusual. Furthermore, the degree of perceived benefit may be shaded by the level of expectation. It is known that current stents placed for malignant biliary strictures will clog eventually, so that benefit for only a few months is what is hoped for. However, a permanently patent stent would obviously be more beneficial.


We should never forget that the value of ERCP treatments remains controversial in many contexts because we simply do not have enough outcomes data from objective prospective long-term clinical studies. The evidence available in specific contexts is discussed in the other articles in this issue. We should be modest (and honest) when recommending ERCP as the best approach for an individual patient.


What are the Risks of ERCP?


Patients and practitioners expect that their endoscopy procedures will go smoothly and according to plan. There are several reasons why they may be disappointed. The procedure may fail technically (eg, incomplete colonoscopy or failed biliary cannulation). It may appear to be successful technically but turn out to be clinically unhelpful (eg, a diagnosis missed or an unsuccessful treatment), or there may be an early relapse (eg, stent dysfunction). In addition, some patients and relatives may be disappointed by discourtesy and poor communications, even when everything otherwise works well.


The most feared negative outcome is when something “goes wrong” and the patient suffers a “complication.” This term has unfortunate medicolegal connotations, and is perhaps better avoided. Describing these deviations from the plan as “unplanned events” fits nicely with the principles of informed consent, but the term “adverse events” is now in common parlance.


Adverse events can happen before the endoscope is introduced (eg, a reaction to prophylactic antibiotics or bowel-cleansing preparation), during the procedure (eg, hypoxia), immediately afterward (eg, pain due to perforation), a few hours later (eg, pancreatitis after ERCP), or can be delayed for several days or weeks (eg, aspiration pneumonia or delayed bleeding). Some events (eg, viral transmission) may be so far delayed that the connection is difficult to make, or is missed completely.


Defining adverse events


There is a substantial literature describing individual adverse events, and many large collected series. A key issue is the need for a standardized nomenclature and agreed definitions for adverse events. For example, what is meant by “hypoxia,” or “bleeding,” or “infection”? At what level do they become significant enough to be “counted”? Another problem is how to classify and report delayed events, which may or may not be attributable to the procedure. This lack of standardization has many consequences. It hampers the comparison of data from different research and quality-improvement studies. It makes individual studies suspect, because practitioners may not be consistent with their own perceptions and definitions. Furthermore, it makes it impossible to compare endoscopic outcomes with those from other disciplines such as surgery. The need for standardized nomenclature has come into closer focus recently with the increasing use of electronic report writers, which demand a lexicon.


Some attempts were made years ago to address this problem, and some 20-year-old definitions for adverse events in ERCP have been widely used, but there has not been consensus across the whole range of endoscopic procedures. The ASGE Quality Task Force convened a workshop in September 2008 to explore the current situation and to make recommendations. Invitations were issued to representatives from the ASGE, the American College of Gastroenterology, and the Society of American Gastrointestinal and Endoscopic Surgeons, and also to those familiar with related lexicons, such as NSQIP (Surgery), HI-IQ (Radiology), NIH, CCTAE (National Cancer Institute), Snomed Clinical Terminology, and the MST. The working party made several recommendations.




  • Recommendations of the ASGE Working Party on Adverse Events


  • 1.

    Definitions and severity criteria should be generic across the different endoscopic procedures, although certain events will occur only after some of them (eg, cholangitis after ERCP).


  • 2.

    An adverse event is one that prevents completion of the planned procedure, and/or results in admission to hospital, or prolongation of existing hospital stay, or (for management of the event) another procedure (one needing sedation/anesthesia), or consultation with another specialty.


  • 3.

    Timing. Events should be recorded as happening preprocedure, intraprocedure (from entering the preparation area through leaving the endoscopy room), postprocedure (up to 14 days), and late (any time after 14 days). For delayed events, the number of days after the procedure should be documented.


  • 4.

    Events should be documented as: definitely attributable, probably, possibly, and not attributable.


  • 5.

    Severity is graded by the degree of consequent disturbance to the patient and any changes in the plan of care. Adverse events should be followed until their conclusion to assess severity, and which should include the outcome of any new procedures required to treat them. Thus death after surgery for debridement of post-ERCP pancreatitis would be attributable to the ERCP. However, this should not apply to adverse events occurring after second procedures done solely because of the technical failure of the initial endoscopy (ie, without any adverse event prompting failure or abortion of the procedure).


  • 6.

    Event tracking. Attempts should be made to contact patients at about 14 days after procedures to determine whether any adverse events have occurred, and whether they are attributable. Report generators should allow these data to be included as an addendum to the endoscopy report, including the statement that there were definitely no adverse events, when this had been confirmed by patient contact.


  • 7.

    Reporting statistics. When reporting “complication rates,” only definite and probably attributable events occurring within 14 days should be included. Rare adverse events that present after 14 days and are clearly attributable can be recorded as a separate category. Examples include a proven nosocomial infection, or stent migration causing a new clinical problem, not just failure of the original treatment goal.


  • 8.

    Incidents are unplanned events that do not interfere with completion of the planned procedure or change the plan of care, that is, do not fulfill the stated criteria for adverse events. Examples include bleeding that stops spontaneously or with endoscopic therapy, and transient hypoxia that resolves with or without reversal agents, supplemental oxygen, or bagging. These incidents should be recorded for the purposes of quality improvement, and perhaps to see which incidents may predict later adverse events. Incidents may occur during the procedure or in the immediate recovery period (ie, while still under supervision).



Risk factors for adverse events


It is self-evident that adverse events are less likely to occur when both the endoscopist and the patient are well prepared for the specific procedure, and if performed with the support of a competent team in an appropriate environment. Issues relating to endoscopist and unit competence have been addressed earlier.


Understanding the risks inherent in specific contexts, and how to defuse them, was addressed recently by another working party of the ASGE. The goal was to examine the evidence for specific risks and to suggest a list of factors that might be included in endoscopy reporting/database systems. The conclusions of a very comprehensive review by Romagnuolo and colleagues were published in 2 parts, relating respectively to the risks for cardiopulmonary events and the remainder, which relate mainly to individual procedure types.


The factors increasing the risk of cardiopulmonary events are obvious, and include advanced age, established cardiac and pulmonary disability, other comorbidities, and obesity. These considerations and a few others are nicely wrapped up in the ASA score, which is a standard entry in most reporting systems. Risk is also affected by the setting for the procedure (eg, intensive care unit), its duration, and who administers the sedation/anesthesia.


There are many generic risk factors that apply to all types of endoscopy, including the type and complexity of any therapeutic activity, active infection, immunosuppression, and spontaneous or therapeutic coagulation deficits. ERCP carries other very specific risks, such as pancreatitis, the predictors for which have been widely researched and documented.


Managing adverse events


There are several rather obvious but important management strategies when things “go wrong.” The author believes that it is important to:



  • 1.

    Recognize the problem quickly, and take appropriate diagnostic and therapeutic actions. Consult other specialists quickly as needed, especially surgeons when there is possibility of perforation (preferably one who knows that not all perforations need surgery).


  • 2.

    Behave professionally, just as you would if things had gone well. Visit regularly, but not excessively. Explain carefully to the patient and family what has happened, referring to the consent process: “The x-ray shows a small perforation. You remember that we discussed that possibility beforehand. I’m sorry that it happened to you. This what we plan to do.”


  • 3.

    Show that you care. Saying “sorry” is simply to show sympathy, not to suggest that you did something wrong. Do not speculate that “I must have pushed too hard or cut too far.” Keep in touch even if a patient is transferred to another service or hospital. Failure to do so may look like abandonment, and can make people angry and out for revenge. One way to show that you care is to give the patient your cell-phone number.


  • 4.

    Ask whether there are other family members in the background (eg, nurses, paralegals) that would appreciate a phone call.



Benefits and Risks to ERCP Endoscopists


Endoscopists performing ERCP gain from their practice in several obvious ways, but they are also exposed to significant risks.


Physical harm


Radiation is an obvious hazard, although no definite damage has been described. It is wise to wear special spectacles, thyroid collars, and wrap-around aprons, and to monitor exposures. Endoscopists performing large numbers of complex ERCPs, and their assistants, should seek professional help from radiation safety officers to further minimize their exposure with customized barriers, such as lead-lined curtains and glass dividers on wheels. The chance of being infected by patients should be eliminated by standard shielding methods. Several surveys have shown significant musculoskeletal issues in endoscopists. Neck problems are more common in older endoscopists who practiced before videoendoscopy, caused by having to crouch over the eyepiece. Some ERCP practitioners have suffered from “cannulator’s thumb” from working the elevator lever.


Medicolegal hazard


ERCP is the most dangerous procedure that endoscopists perform on a regular basis, and some bad outcomes are inevitable. Whether any of these lead to lawsuits is determined by how well endoscopists follow the advice outlined earlier. By far the biggest issue is communication, or lack of it, at all stages of the process. Informed consent is not a piece of paper; it means that the patient fully understands the potential benefits, risks, limitations, and alternatives, and has developed sufficient trust in the people involved to accept the entire package on offer, including the chance of a poor outcome. This process can be assisted by brochures, videos, and interactive Web sites, and by nursing assistants, but must involve an unhurried face-to-face meeting with the endoscopist.


Endoscopists who practice within the accepted standard of care and who communicate well before and after procedures may still get sued, and lose some sleep, but not the suit.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Sep 12, 2017 | Posted by in GASTOINESTINAL SURGERY | Comments Off on Endoscopic Retrograde Cholangiopancreatography

Full access? Get Clinical Tree

Get Clinical Tree app for offline access